361 related articles for article (PubMed ID: 11023097)
1. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
[TBL] [Abstract][Full Text] [Related]
2. [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors].
Chen Z; Shi H; Ying L; Zhai X; Fu X; Liu Q; Lou S
Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):320-2. PubMed ID: 26178213
[TBL] [Abstract][Full Text] [Related]
3. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
[TBL] [Abstract][Full Text] [Related]
5. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
[TBL] [Abstract][Full Text] [Related]
6. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R
JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358
[TBL] [Abstract][Full Text] [Related]
7. Solid-pseudopapillary tumor of the pancreas: its origin revisited.
Kosmahl M; Seada LS; Jänig U; Harms D; Klöppel G
Virchows Arch; 2000 May; 436(5):473-80. PubMed ID: 10881741
[TBL] [Abstract][Full Text] [Related]
8. [Pediatric pancreatic lesions: a clinicopathological analysis of 42 cases].
Gao Q; Xu H; Wang FH; Yi P; Yang TY; Li LP; Xia JQ; Zeng RX; Niu HL
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):861-867. PubMed ID: 36097903
[No Abstract] [Full Text] [Related]
9. Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique.
Li L; Li J; Hao C; Zhang C; Mu K; Wang Y; Zhang T
Cancer Lett; 2011 Nov; 310(1):9-14. PubMed ID: 21775056
[TBL] [Abstract][Full Text] [Related]
10. Solid-papillary tumors of the pancreas: histopathology.
Santini D; Poli F; Lega S
JOP; 2006 Jan; 7(1):131-6. PubMed ID: 16407635
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
12. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N
World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
[TBL] [Abstract][Full Text] [Related]
15. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
[TBL] [Abstract][Full Text] [Related]
16. Solid pseudopapillary tumor of the pancreas: emphasis on differential diagnosis from aggressive tumors of the pancreas.
Aydiner F; Erinanç H; Savaş B; Erden E; Karayalçin K
Turk J Gastroenterol; 2006 Sep; 17(3):219-22. PubMed ID: 16941259
[TBL] [Abstract][Full Text] [Related]
17. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
Sangoi AR; Ohgami RS; Pai RK; Beck AH; McKenney JK; Pai RK
Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
[TBL] [Abstract][Full Text] [Related]
18. Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q.
Tiemann K; Heitling U; Kosmahl M; Klöppel G
Mod Pathol; 2007 Sep; 20(9):955-60. PubMed ID: 17632456
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas.
Nguyen NQ; Johns AL; Gill AJ; Ring N; Chang DK; Clarkson A; Merrett ND; Kench JG; Colvin EK; Scarlett CJ; Biankin AV
J Gastroenterol Hepatol; 2011 Feb; 26(2):267-74. PubMed ID: 21261715
[TBL] [Abstract][Full Text] [Related]
20. The clear cell variant of solid pseudopapillary tumor of the pancreas: a previously unrecognized pancreatic neoplasm.
Albores-Saavedra J; Simpson KW; Bilello SJ
Am J Surg Pathol; 2006 Oct; 30(10):1237-42. PubMed ID: 17001153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]